CPT1B and colorectal cancer: By using a combined approach of Microarray-Bioinformatic technologies, the authors have revealed the overexpression of CPT1B in clinical tissue specimens of colorectal cancer, demonstrating a potential metabolic mechanism contributing to colorectal cancer.